Yu‐Jeong Choi

618 total citations
43 papers, 450 citations indexed

About

Yu‐Jeong Choi is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Yu‐Jeong Choi has authored 43 papers receiving a total of 450 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 9 papers in Cancer Research and 8 papers in Oncology. Recurrent topics in Yu‐Jeong Choi's work include Phytochemicals and Antioxidant Activities (4 papers), Cancer, Hypoxia, and Metabolism (4 papers) and Computational Drug Discovery Methods (4 papers). Yu‐Jeong Choi is often cited by papers focused on Phytochemicals and Antioxidant Activities (4 papers), Cancer, Hypoxia, and Metabolism (4 papers) and Computational Drug Discovery Methods (4 papers). Yu‐Jeong Choi collaborates with scholars based in South Korea, United States and South Africa. Yu‐Jeong Choi's co-authors include Seong‐Gyu Ko, Sang-Im Yun, Young-Min Lee, Kangwook Lee, Youn Kyung Choi, Byung-Hak Song, Hyo In Kim, Sung‐Gook Cho, Tai Young Kim and Chunhoo Cheon and has published in prestigious journals such as Cancer Research, Journal of Virology and Scientific Reports.

In The Last Decade

Yu‐Jeong Choi

38 papers receiving 443 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yu‐Jeong Choi South Korea 12 187 77 75 68 56 43 450
Ayako Hara Japan 13 271 1.4× 47 0.6× 72 1.0× 34 0.5× 49 0.9× 28 605
Adel Galal El-Shemi Saudi Arabia 15 177 0.9× 35 0.5× 63 0.8× 89 1.3× 34 0.6× 41 668
Jianfeng Fu China 11 228 1.2× 47 0.6× 81 1.1× 34 0.5× 20 0.4× 20 454
Che‐Fang Hsu Taiwan 9 228 1.2× 66 0.9× 21 0.3× 77 1.1× 101 1.8× 20 609
Yaser Gamallat China 15 496 2.7× 87 1.1× 51 0.7× 87 1.3× 39 0.7× 34 765
Alfonso Barreto Colombia 16 328 1.8× 76 1.0× 63 0.8× 136 2.0× 16 0.3× 42 664
Serdal Arslan Türkiye 13 210 1.1× 162 2.1× 109 1.5× 28 0.4× 65 1.2× 32 533
Ajab Khan China 14 174 0.9× 52 0.7× 37 0.5× 32 0.5× 21 0.4× 34 443
Naohisa Tsutsui Japan 11 196 1.0× 27 0.4× 51 0.7× 74 1.1× 47 0.8× 20 531
Preeti Bajpai India 13 161 0.9× 27 0.4× 67 0.9× 34 0.5× 68 1.2× 31 431

Countries citing papers authored by Yu‐Jeong Choi

Since Specialization
Citations

This map shows the geographic impact of Yu‐Jeong Choi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu‐Jeong Choi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu‐Jeong Choi more than expected).

Fields of papers citing papers by Yu‐Jeong Choi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu‐Jeong Choi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu‐Jeong Choi. The network helps show where Yu‐Jeong Choi may publish in the future.

Co-authorship network of co-authors of Yu‐Jeong Choi

This figure shows the co-authorship network connecting the top 25 collaborators of Yu‐Jeong Choi. A scholar is included among the top collaborators of Yu‐Jeong Choi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu‐Jeong Choi. Yu‐Jeong Choi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Choi, Yu‐Jeong, et al.. (2025). The combination of SH003 and DTX induces cytotoxic cell infiltration in anti-PD1 resistant lung cancer. Cancer Immunology Immunotherapy. 74(7). 198–198. 3 indexed citations
2.
Choi, Yu‐Jeong, et al.. (2024). Scalable production of siRNA‐encapsulated extracellular vesicles for the inhibition of KRAS‐mutant cancer using acoustic shock waves. Journal of Extracellular Vesicles. 13(9). e12508–e12508. 5 indexed citations
3.
Lee, Kangwook, et al.. (2024). Network pharmacology study to explore the multiple molecular mechanism of SH003 in the treatment of non-small cell lung cancer. BMC Complementary Medicine and Therapies. 24(1). 70–70. 2 indexed citations
4.
Ku, Jin Mo, Min-Jeong Kim, Yu‐Jeong Choi, et al.. (2023). JI017 Induces Cell Autophagy and Apoptosis via Elevated Levels of Reactive Oxygen Species in Human Lung Cancer Cells. International Journal of Molecular Sciences. 24(8). 7528–7528. 8 indexed citations
5.
Choi, Yu‐Jeong, Youn Kyung Choi, Seong‐Gyu Ko, Chunhoo Cheon, & Tai Young Kim. (2023). Investigation of Molecular Mechanisms Involved in Sensitivity to the Anti-Cancer Activity of Costunolide in Breast Cancer Cells. International Journal of Molecular Sciences. 24(4). 4009–4009. 11 indexed citations
6.
El‐Damasy, Ashraf K., Jong‐Min Oh, Ahmed A. Al‐Karmalawy, et al.. (2023). Novel coumarin benzamides as potent and reversible monoamine oxidase-B inhibitors: Design, synthesis, and neuroprotective effects. Bioorganic Chemistry. 142. 106939–106939. 8 indexed citations
7.
Kim, Min Jeong, Jin Mo Ku, Yu‐Jeong Choi, et al.. (2022). Reduced HIF-1α Stability Induced by 6-Gingerol Inhibits Lung Cancer Growth through the Induction of Cell Death. Molecules. 27(7). 2106–2106. 6 indexed citations
8.
Choi, Yu‐Jeong, Kangwook Lee, Ji‐Hye Yoon, et al.. (2022). SH003 and Docetaxel Show Synergistic Anticancer Effects by Inhibiting EGFR Activation in Triple‐Negative Breast Cancer. BioMed Research International. 2022(1). 3647900–3647900. 11 indexed citations
9.
Choi, Yu‐Jeong, et al.. (2022). Metabolomic Analysis of Exosomes Derived from Lung Cancer Cell Line H460 Treated with SH003 and Docetaxel. Metabolites. 12(11). 1037–1037. 7 indexed citations
10.
Lee, Kangwook, et al.. (2022). State of the Art and Future Implications of SH003: Acting as a Therapeutic Anticancer Agent. Cancers. 14(4). 1089–1089. 9 indexed citations
11.
Lee, Kangwook, et al.. (2021). Herbal Prescription SH003 Alleviates Docetaxel-Induced Neuropathic Pain in C57BL/6 Mice. Evidence-based Complementary and Alternative Medicine. 2021. 1–10. 16 indexed citations
12.
Lee, Kangwook, Jin Mo Ku, Yu‐Jeong Choi, et al.. (2020). Cucurbitacin D Induces G2/M Phase Arrest and Apoptosis via the ROS/p38 Pathway in Capan‐1 Pancreatic Cancer Cell Line. Evidence-based Complementary and Alternative Medicine. 2020(1). 6571674–6571674. 14 indexed citations
13.
Kang, Soo‐Yeon, Hyo In Kim, Yu‐Jeong Choi, et al.. (2019). Traditional Herbal Formula Taeeumjowi-Tang (TJ001) Inhibits p53-Mutant Prostate Cancer Cells Growth by Activating AMPK-Dependent Pathway. Evidence-based Complementary and Alternative Medicine. 2019. 1–11. 3 indexed citations
14.
Choi, Yu‐Jeong, Soo‐Yeon Kang, Seoyeon Lee, et al.. (2019). Abstract 2603: Herbal extract SH003 suppresses tumor growth and metastasis of MDA-MB-231 breast cancer cells by inhibiting STAT3-IL-6 signaling. Cancer Research. 79(13_Supplement). 2603–2603. 1 indexed citations
15.
Lee, Kangwook, Sung‐Gook Cho, Yu‐Jeong Choi, et al.. (2017). Inhibitory effect of ucha‐shinki‐hwan on cold‐mediated response in human dermal microvascular endothelial cells. Traditional & Kampo Medicine. 4(2). 105–110.
16.
Lee, Kangwook, et al.. (2017). Herbal prescription, Danggui-Sayuk-Ga-Osuyu-Senggang-Tang, inhibits TNF-α-induced epithelial-mesenchymal transition in HCT116 colorectal cancer cells. International Journal of Molecular Medicine. 41(1). 373–380. 8 indexed citations
17.
Lee, Kang Min, et al.. (2017). SH003-induced G1 phase cell cycle arrest induces apoptosis in HeLa cervical cancer cells. Molecular Medicine Reports. 16(6). 8237–8244. 26 indexed citations
18.
Choi, Yu‐Jeong, et al.. (2016). SH003 induces apoptosis of DU145 prostate cancer cells by inhibiting ERK-involved pathway. BMC Complementary and Alternative Medicine. 16(1). 507–507. 40 indexed citations
19.
Yun, Sang-Im, et al.. (2009). Expression and Antibody Production of Japanese Encephalitis Virus RNA Polymerase (NS5) Protein. Journal of Bacteriology and Virology. 39(1). 53–53. 1 indexed citations
20.
Song, Byung-Hak, et al.. (2008). A complex RNA motif defined by three discontinuous 5-nucleotide-long strands is essential for Flavivirus RNA replication. RNA. 14(9). 1791–1813. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ayako Hara Breakdown of academic impact, for papers by Adel Galal El-Shemi Breakdown of academic impact, for papers by Jianfeng Fu Breakdown of academic impact, for papers by Che‐Fang Hsu Breakdown of academic impact, for papers by Yaser Gamallat Breakdown of academic impact, for papers by Alfonso Barreto Breakdown of academic impact, for papers by Serdal Arslan Breakdown of academic impact, for papers by Ajab Khan Breakdown of academic impact, for papers by Naohisa Tsutsui Breakdown of academic impact, for papers by Preeti Bajpai
Rankless by CCL
2026